Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence90
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer72
Cost analyses for malaria molecular diagnosis for research planners in India and beyond67
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features52
What makes a « good » companion diagnostic in thoracic oncology?46
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA36
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination34
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling32
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment31
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma30
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects30
Polygenic and Network-based studies in risk identification and demystification of cancer29
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer29
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer27
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis27
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study26
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome25
Nuclease activity: an exploitable biomarker in bacterial infections25
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?25
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology24
The MALAT1-breast cancer interplay: insights and implications24
The current and future applications of in situ hybridization technologies in anatomical pathology22
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma22
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study22
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma22
0.19571089744568